Par Drugs and Chemicals Ltd. (PAR) — NSE Stock Analysis
Sector: Healthcare. Industry: Drug Manufacturers - Specialty & Generic. Share price: ₹90.70.
Company Overview
Par Drugs and Chemicals Limited develops, manufactures, and sells active pharmaceutical ingredients (APIs) and fine chemicals in India. The company provides API products, including magnesium hydroxide, magnesium oxide USP, sucralfate, almagate BP, dried aluminium hydroxide gel, light magnesium carbonate, magaldrate, magnesium trisilicate, colloidal silicon dioxide, aluminium magnesium silicate, magnesium aluminometasilicate, magnesium aluminosilicate-USP, magnesium oxide light, magnesium oxide heavy, magnesium aluminium hydrate, hydrotalcite, and synthetic aluminium silicate. It offers fine chemicals, such as precipitated silica, sodium aluminium silicate, amorphous aluminium hydroxide, PARSIL-HT, PAR ADD OP, MagSil OF, FlowSil, aluminium hydroxide magnesium carbonate co-dried gel, magnesium aluminium silicate hydrated (pharma), and magnesium aluminium silicate hydrated (agro). It exports its products to Germany, the United Kingdom, Bangladesh, Iran, the United Arab Emirates, Indonesia, Japan, South Korea, and internationally. Par Drugs and Chemicals Limited was founded in 1982 and is based in Vadodara, India.
Valuation Snapshot
- Market cap: —
- P/E: —
- P/B: —
- ROE: —
Blanket Finance is not a SEBI-registered investment adviser or research analyst. This content is for educational and informational purposes only.